Christopher L. Bowlus
- Hepatology top 0.1%
- Liver Diseases and Immunity 156
- Liver Disease and Transplantation 17
- Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment 111
- Hepatitis B Virus Studies 17
- Surgery top 0.5%
- Pediatric Hepatobiliary Diseases and Treatments 52
- Cholangiocarcinoma and Gallbladder Cancer Studies 14
- Oncology top 2%
- Drug Transport and Resistance Mechanisms 22
-
- Gallbladder and Bile Duct Disorders 38
- Co-authors
- M. Eric GershwinCynthia LevyKeith D. LindorRoss L. CoppelMarlyn J. MayoJohn H. HolcombeMatthew WintleJohn B. Buse
- Cited by
- HepatologyEpidemiologySurgery
- Journals
- Proceedings of the National Academy of Sciences (1 paper)The Lancet (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Christopher L. Bowlus
217 papers receiving 8.7k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Hepatology 4.9k
- Epidemiology 4.0k
- Surgery 3.2k
- Endocrinology, Diabetes and Metabolism 1.1k
- Oncology 1.2k
Countries citing papers authored by Christopher L. Bowlus
This map shows the geographic impact of Christopher L. Bowlus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Bowlus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Bowlus more than expected).
Fields of papers citing papers by Christopher L. Bowlus
This network shows the impact of papers produced by Christopher L. Bowlus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Bowlus. The network helps show where Christopher L. Bowlus may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christopher L. Bowlus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 14 | |
| 8 | 2023 | 22 | |
| 9 | 2023 | 22 | |
| 10 | 2022 | 6 | |
| 11 | 2021 | 0 | |
| 12 | 2021 | 14 | |
| 13 | 2021 | 63 | |
| 14 | 2020 | 35 | |
| 15 | 2019 | 28 | |
| 16 | The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC. | 2019 | 3 |
| 17 | 2016 | 70 | |
| 18 | 2016 | 16 | |
| 19 | Hepatic expression of lysyl oxidase-like-2 ( LOXL2) in primary sclerosing cholangitis (PSC) | 2016 | 3 |
| 20 | 2006 | 128 |
About Christopher L. Bowlus
Christopher L. Bowlus is a scholar working on Hepatology, Epidemiology and Surgery, having authored 231 papers that have together received 8.9k indexed citations. Recurring topics across this work include Liver Diseases and Immunity (156 papers), Liver Disease Diagnosis and Treatment (111 papers), Pediatric Hepatobiliary Diseases and Treatments (52 papers), Gallbladder and Bile Duct Disorders (38 papers), Drug Transport and Resistance Mechanisms (22 papers), Liver Disease and Transplantation (17 papers), Hepatitis B Virus Studies (17 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers). The work is most often cited by research in Hepatology (4.9k citations), Epidemiology (4.0k citations) and Surgery (3.2k citations). Christopher L. Bowlus has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include M. Eric Gershwin, Cynthia Levy, Keith D. Lindor, Ross L. Coppel, Marlyn J. Mayo, John H. Holcombe, Matthew Wintle, John B. Buse, David C. Klonoff and Loretta L. Nielsen. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.